SMOOTH - Blood Pressure Control in Diabetic/Obese Patients

NCT00239538 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

840

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension
Diabetes Mellitus, Type 2

Interventions

DRUG: telmisartan combined with hydrochlorothiazide (80/12.5 mg)
DRUG: valsartan combined with hydrochlorothiazide (160/12.5mg)

Sponsor

Boehringer Ingelheim